G. Hardavella (Athens, Greece), M. Pereira Catarata (Porto, Portugal)
Introduction
G. Hardavella (Athens, Greece), M. Pereira Catarata (Porto, Portugal)
|  |
Implementation of lung cancer screening: an European survey
J. van Meerbeeck (Edegem (Antwerp), Belgium), A. Snoeckx (Edegem (Antwerp), Belgium)
|   |
Pilot lung cancer screening program results in Serbia during 1-year period
J. Djekic Malbasa (Novi Sad, Republic of Serbia), T. Kovacevic (Novi Sad, Republic of Serbia), D. Bokan (Novi Sad, Republic of Serbia), B. Zaric (Novi Sad, Republic of Serbia), S. Bojanic (Novi Sad, Republic of Serbia), D. Dragisic (Novi Sad, Republic of Serbia)
|  |
Radiomics to increase the effectiveness of lung cancer screening programs. Radiolung preliminary results.
A. Rosell Gratacos (Badalona (Barcelona), Spain), S. Baeza (Badalona (Barcelona), Spain), S. Garcia-Reina (Badalona (Barcelona), Spain), J. Mate (Badalona (Barcelona), Spain), I. Guasch (Badalona (Barcelona), Spain), I. Nogueira (Badalona (Barcelona), Spain), I. Garcia-Olivé (Badalona (Barcelona), Spain), G. Torres (Barcelona, Spain), C. Sànchez-Ramos (Barcelona, Spain), D. Gil (Barcelona, Spain)
| |
Radiology quality assurance in the Yorkshire Lung Screening Trial.
S. Upperton (Leeds, United Kingdom), C. Bradley (Craigavon, United Kingdom), B. Bhartia (Leeds, United Kingdom), P. Crosbie (Manchester, United Kingdom), M. Darby (Leeds, United Kingdom), R. Gabe (London, United Kingdom), N. Hancock (Leeds, United Kingdom), M. Kennedy (Leeds, United Kingdom), M. Callister (Leeds, United Kingdom)
| |
A novel method exhale breath fingerprinting for lung cancer diagnosis by selected ion monitoring mode
L. Pelit (Izmir, Turkey), T. Dizdas (Izmir, Turkey), A. Arin (Izmir, Turkey), S. Özgür (Izmir, Turkey), I. Erbas (Izmir, Turkey), O. Goksel (Izmir, Turkey), F. Pelit (Izmir, Turkey), B. Ordin (Izmir, Turkey), H. Karakus (Izmir, Turkey), A. Gursoy (Izmir, Turkey), F. Ertas (Izmir, Turkey), T. Göksel (Izmir, Turkey)
| |
Diagnosing non-small cell lung cancer by exhaled-breath profiling using an electronic nose: a multicentre validation study.
S. Kort (Enschede, Netherlands), M. Brusse - Keizer (Enschede, Netherlands), H. Schouwink (Enschede, Netherlands), E. Citgez (Enschede, Netherlands), F. De Jongh (Enschede, Netherlands), J. Van Putten (Groningen, Netherlands), B. Van Den Borne (Eindhoven, Netherlands), L. Kastelijn (Utrecht, Netherlands), D. Stolz (Basel, Switzerland), M. Schuurbiers (Nijmegen, Netherlands), M. Van Den Heuvel (Nijmegen, Netherlands), W. Van Geffen (Leeuwarden, Netherlands), J. Van Der Palen (Leeuwarden, Netherlands)
| |
Particles in exhaled air – a new diagnostic tool for patients with lung adenocarcinoma
J. Andreasson (Lund, Sweden), E. Bodén (Lund, Sweden), G. Hirdman (Lund, Sweden), C. Von Wachter (Munich, Germany), O. Hallgren (Lund, Sweden), M. Fakhro (Copenhagen, Denmark), F. Olm (Lund, Sweden), S. Lindstedt (Lund, Sweden)
| |
Late Breaking Abstract - Incidence of lung cancer in Chronic Obstructive Pulmonary Disease (COPD) patients: Prognostic factors and survival analysis
P. Niyomthong (Phrae, Thailand)
| |
Late Breaking Abstract - Safety and feasibility of a novel externally cooled bronchoscopic radiofrequency ablation catheter for ablation of peripheral lung tumours: a first-in-human dose escalation study
D. Steinfort (Melbourne, Australia), P. Antippa (Melbourne, Australia), K. Rangamuwa (Melbourne, Australia), L. Irving (Melbourne, Australia), M. Christie (Melbourne, Australia), E. Chan (Melbourne, Australia), D. Tanaka (Cupertino, United States), K. Yoneda (Sacramento, United States), J. Christie (Melbourne, Australia), F. Herth (Heidelberg, Germany), S. Raina (Santa Clara, United States)
| |
Discussion
| |